Good morning :)
$
₹
C

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

CUPR

NASDAQ
C

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

CUPR

NASDAQ
$2.986.59% (-0.21)
$
₹
$2.986.59% (-0.21)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Micro Cap

With a market cap of $8.4M the stock is ranked 5793

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.11
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-1.44
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

Peers

Peers

Medline Inc. Class A Common Stock
MDLN
M
P/E Ratio
40.66
40.66
1Y Return
20.51%
20.51%
Buy Reco %
—
—
West Pharmaceutical Services Inc
WST
West Pharmaceutical Services Inc
P/E Ratio
44.27
44.27
1Y Return
38.03%
38.03%
Buy Reco %
92.30
92.30
Align Technology Inc
ALGN
Align Technology Inc
P/E Ratio
26.18
26.18
1Y Return
16.74%
16.74%
Buy Reco %
61.11
61.11
The Cooper Companies, Inc
COO
The Cooper Companies, Inc
P/E Ratio
18.52
18.52
1Y Return
17.19%
17.19%
Buy Reco %
57.89
57.89
Lantheus Holdings Inc
LNTH
Lantheus Holdings Inc
P/E Ratio
23.98
23.98
1Y Return
93.89%
93.89%
Buy Reco %
92.30
92.30

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares -2.11-
Medline Inc. Class A Common Stock40.662.46-
West Pharmaceutical Services Inc44.278.142.69

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

0
-2.6
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Revenue
Net Income
Financial YearQ4 2022Q2 2023Q4 2023Q2 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Total Revenue---------0.02
Net Income----------2.68
Net Profit Margin----------10039.18%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) share price today is $2.98 as of September 16, 2026 at 12:03 AM IST. The stock touched a day high of $3.21 and a day low of $2.93.

  2. Cuprina Holdings (Cayman) Limited Class A Ordinary Shares stock trades on NASDAQ under the ticker symbol CUPR.

  3. Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's market capitalization is $8.44M as of September 16, 2026 at 12:03 AM IST.

  4. Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's price-to-earnings (P/E) ratio is N/A as of September 15, 2026.

  5. Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's price-to-book (P/B) ratio is 2.11 as of September 15, 2026.

  6. Yes, You can buy Cuprina Holdings (Cayman) Limited Class A Ordinary Shares shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Cuprina Holdings (Cayman) Limited Class A Ordinary Shares shares in three steps: 1. Search Cuprina Holdings (Cayman) Limited Class A Ordinary Shares on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Cuprina Holdings (Cayman) Limited Class A Ordinary Shares trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 3.3456 shares at the current price of $2.98.

Loading...